Linli Yao

1.7k total citations
44 papers, 1.2k citations indexed

About

Linli Yao is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Linli Yao has authored 44 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 18 papers in Oncology and 11 papers in Cancer Research. Recurrent topics in Linli Yao's work include Cancer Immunotherapy and Biomarkers (6 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Advanced biosensing and bioanalysis techniques (5 papers). Linli Yao is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Advanced biosensing and bioanalysis techniques (5 papers). Linli Yao collaborates with scholars based in China, Singapore and United States. Linli Yao's co-authors include Eng‐Ang Ling, Aijun Hao, Enci Mary Kan, Charanjit Kaur, Jia Lu, S. Thameem Dheen, Shengfu Wang, Xun Zhang, Lebao Mao and Wei Wen and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Linli Yao

42 papers receiving 1.2k citations

Peers

Linli Yao
Haiyan Lu China
Kaiyuan Wang China
Ping Lei China
Yu Cui China
Hyunduk Jang South Korea
Shengdong Wang China
Megumi Watanabe Japan
Shuxia Zhang China
Lijuan Li China
Haiyan Lu China
Linli Yao
Citations per year, relative to Linli Yao Linli Yao (= 1×) peers Haiyan Lu

Countries citing papers authored by Linli Yao

Since Specialization
Citations

This map shows the geographic impact of Linli Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linli Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linli Yao more than expected).

Fields of papers citing papers by Linli Yao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linli Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linli Yao. The network helps show where Linli Yao may publish in the future.

Co-authorship network of co-authors of Linli Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Linli Yao. A scholar is included among the top collaborators of Linli Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linli Yao. Linli Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ye, Qingsong, Shan Zhang, Xiaoqi Wang, et al.. (2025). Vitamin K‐dependent gamma‐carboxyglutamic acid protein 1 promotes pancreatic ductal adenocarcinoma progression through stabilizing oncoprotein KRAS and tyrosine kinase receptor EGFR. Clinical and Translational Medicine. 15(1). e70191–e70191. 3 indexed citations
3.
Yao, Linli, et al.. (2025). Asparagine endopeptidase regulates lysosome homeostasis via modulating endomembrane phosphoinositide composition. Cell Death and Disease. 15(12). 883–883. 3 indexed citations
4.
5.
6.
Yao, Hong‐Fei, Peng Liu, Linli Yao, & Xiao Li. (2024). Establishment of disulfidptosis-related LncRNA signature as biomarkers in colon adenocarcinoma. Cancer Cell International. 24(1). 183–183. 3 indexed citations
7.
Dong, Fangyuan, Hui Li, Limin Liu, et al.. (2023). ACE2 negatively regulates the Warburg effect and suppresses hepatocellular carcinoma progression via reducing ROS-HIF1α activity. International Journal of Biological Sciences. 19(8). 2613–2629. 16 indexed citations
8.
Yuan, Zhihao, Siteng Chen, Xiongjun Wang, et al.. (2023). Competition between p53 and YY1 determines PHGDH expression and malignancy in bladder cancer. Cellular Oncology. 46(5). 1457–1472. 6 indexed citations
9.
Yao, Linli, Qing Li, Pei-Qi Huang, et al.. (2023). The SLITRK4-CNPY3 axis promotes liver metastasis of gastric cancer by enhancing the endocytosis and recycling of TrkB in tumour cells. Cellular Oncology. 46(4). 1049–1067. 12 indexed citations
10.
Huang, Shan, Naiqi Zhang, Chunjie Xu, et al.. (2023). Dipyridamole enhances the anti-cancer ability of aspirin against colorectal cancer by inducing apoptosis in an unfolded protein response-dependent manner. Cellular Oncology. 46(4). 953–967. 6 indexed citations
11.
Yao, Linli, Xiaonan Sheng, Weihang Zhou, et al.. (2023). Neutrophil extracellular traps mediate TLR9/Merlin axis to resist ferroptosis and promote triple negative breast cancer progression. APOPTOSIS. 28(9-10). 1484–1495. 27 indexed citations
12.
Tian, Guang-Ang, Xueli Zhang, Yaoqi Zhou, et al.. (2023). CCBE1 promotes mitochondrial fusion by inhibiting the TGFβ-DRP1 axis to prevent the progression of hepatocellular carcinoma. Matrix Biology. 117. 31–45. 8 indexed citations
13.
Wang, Xu, Li-Peng Hu, Weiting Qin, et al.. (2021). Identification of a subset of immunosuppressive P2RX1-negative neutrophils in pancreatic cancer liver metastasis. Nature Communications. 12(1). 174–174. 87 indexed citations
14.
Hu, Li-Peng, Yan‐Miao Huo, Dejun Liu, et al.. (2021). Single-cell RNA sequencing reveals that targeting HSP90 suppresses PDAC progression by restraining mitochondrial bioenergetics. Oncogenesis. 10(3). 22–22. 8 indexed citations
15.
Hu, Huabin, Mengting Liao, Yin Shi, et al.. (2020). Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab vs. Chemotherapy as First-Line Therapy in Advanced Non-Small Cell Lung Cancer. Frontiers in Oncology. 10. 1649–1649. 33 indexed citations
16.
Ding, Dong, Huabin Hu, Mengting Liao, et al.. (2020). Cost-Effectiveness Analysis of Atezolizumab Plus Chemotherapy in the First-Line Treatment of Metastatic Non-Squamous Non-Small Cell Lung Cancer. Advances in Therapy. 37(5). 2116–2126. 23 indexed citations
17.
18.
Yao, Linli, Pengfei Lu, & Eng‐Ang Ling. (2016). Melatonin Suppresses Toll Like Receptor 4-Dependent Caspase-3 Signaling Activation Coupled with Reduced Production of Proinflammatory Mediators in Hypoxic Microglia. PLoS ONE. 11(11). e0166010–e0166010. 25 indexed citations
19.
Yao, Linli, Enci Mary Kan, Jia Lu, et al.. (2013). Toll-like receptor 4 mediates microglial activation and production of inflammatory mediators in neonatal rat brain following hypoxia: role of TLR4 in hypoxic microglia. Journal of Neuroinflammation. 10(1). 23–23. 252 indexed citations
20.
Kan, Enci Mary, Lu Jia, Kian Chye Ng, et al.. (2013). Primary blast injury-induced lesions in the retina of adult rats. Journal of Neuroinflammation. 10(1). 79–79. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Haiyan Lu Breakdown of academic impact, for papers by Kaiyuan Wang Breakdown of academic impact, for papers by Ping Lei Breakdown of academic impact, for papers by Yu Cui Breakdown of academic impact, for papers by Hyunduk Jang Breakdown of academic impact, for papers by Shengdong Wang Breakdown of academic impact, for papers by Megumi Watanabe Breakdown of academic impact, for papers by Shuxia Zhang Breakdown of academic impact, for papers by Lijuan Li
Rankless by CCL
2026